Our data indicated that in NSCLC cells, PIK3 signalling is required in vitro and in vivo since suppression of p110α expression inhibits the growth of xenografted cells carrying an activated PIK3CA allele. The gene discussed is PIK3CG; the disease is non-small cell lung carcinoma.